FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to haematology, and is applicable for immune response modulation, particularly for prevention of acute graft-versus-host disease following marrow allografting. Donor multipotent mesenchymal stromal cells recovered from bone marrow, cultured on a human blood plasma medium enriched in platelet lysate are introduced intravenously in the amount of 1x106 grafted cells per one kg of patient's body weight at the moment of leukocyte recovery in patient's peripheral blood following marrow allografting min. 1.0×109/l.
EFFECT: method provides effective prevention of acute graft-versus-host disease following marrow allografting.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SEPTIC SHOCK ACCOMPANIED WITH AGRANULOCYTOSIS | 2015 |
|
RU2604672C1 |
| METHOD OF GLOBULAR BLOOD VOLUME CONTROL AND IMMUNOMODULATION ACCOMPANYING TRANSPLANTATION | 2011 |
|
RU2452519C1 |
| METHOD OF TREATING RECURRENT ACUTE MYELOID LEUKAEMIA FOLLOWING TRANSPLANTATION OF ALLOGENIC HAEMOPOIETIC STEM CELLS | 2013 |
|
RU2538799C1 |
| BIOCOMPOSITE SPHEROID FOR BONE REPAIR AND METHOD OF ITS PREPARATION | 2020 |
|
RU2744732C1 |
| METHOD OF MODULATING POST-TRANSPLANTATION CHANGING IN KIDNEYS | 2014 |
|
RU2557701C1 |
| METHOD OF TREATING ACUTE HEPATIC IMPAIRMENT | 2018 |
|
RU2701792C1 |
| BIO TRANSPLANT FOR THE JOINTS DYSPLASIA TREATMENT AND METHOD OF ITS PREPARATION | 2017 |
|
RU2659204C1 |
| USE OF TOTAL RIBONUCLEIC ACID (RNA) FROM MULTIPOTENT MESENCHYMAL STROMAL CELLS OF THE MAMMAL'S BONE MARROW AS METHOD FOR CORRECTING LIVER FAILURE | 2017 |
|
RU2655761C1 |
| METHOD FOR CORD BLOOD MONONUCLEAR CELLS (cbMNC) EXPANSION ex vivo IN PRESENCE OF MULTIPOTENT MESENCHYMAL STROMAL CELLS (MMSCS) | 2013 |
|
RU2525143C1 |
| METHOD OF TREATING HEPATIC FAILURE | 2017 |
|
RU2655528C1 |
